PMGC HOLDINGS INC. Disposal Group, Including Discontinued Operation, General and Administrative Expense
PMGC HOLDINGS INC. (ELAB) reported Disposal Group, Including Discontinued Operation, General and Administrative Expense of $56.76 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense · last filed 2026-08-14
- PMGC HOLDINGS INC. disposal group, including discontinued operation, general and administrative expense for the quarter ending 2025-12-31 was $1.80K, a 99.55% decline year-over-year.
- PMGC HOLDINGS INC. disposal group, including discontinued operation, general and administrative expense for the quarter ending 2025-09-30 was $83.00, a 99.98% decline year-over-year.
- PMGC HOLDINGS INC. disposal group, including discontinued operation, general and administrative expense for the quarter ending 2025-06-30 was $7.66K, a 98.51% decline year-over-year.
- PMGC HOLDINGS INC. disposal group, including discontinued operation, general and administrative expense for the quarter ending 2025-03-31 was $47.21K, a 93.67% decline year-over-year.
- PMGC HOLDINGS INC. disposal group, including discontinued operation, general and administrative expense for fiscal 2025 was $56.76K, a 97.23% decline from fiscal 2024.
- PMGC HOLDINGS INC. disposal group, including discontinued operation, general and administrative expense for fiscal 2024 was $2.05M, a 3.54% increase from fiscal 2023.
- PMGC HOLDINGS INC. disposal group, including discontinued operation, general and administrative expense for fiscal 2023 was $1.98M.
| Period end | Disposal Group, Including Discontinued Operation, General and Administrative Expense 3 month | Disposal Group, Including Discontinued Operation, General and Administrative Expense 6 month | Disposal Group, Including Discontinued Operation, General and Administrative Expense 9 month | Disposal Group, Including Discontinued Operation, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2025-12-31 | $1.80K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $1.89K derived: sum of 2 quarters · filed 2026-03-30 | $9.55K derived: sum of 3 quarters · filed 2026-08-14 | $56.76K 10-K · filed 2026-03-30 |
| 2025-09-30 | $83.00 10-Q · filed 2025-11-14 | $7.74K derived: sum of 2 quarters · filed 2026-08-14 | $54.96K 10-Q · filed 2025-11-14 | $458.03K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $7.66K 10-Q · filed 2026-08-14 | $54.88K 10-Q · filed 2026-08-14 | $457.95K derived: sum of 3 quarters · filed 2026-08-14 | $844.68K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $47.21K 10-Q · filed 2026-05-15 | $450.29K derived: sum of 2 quarters · filed 2026-05-15 | $837.02K derived: sum of 3 quarters · filed 2026-05-15 | $1.35M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $403.07K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $789.81K derived: sum of 2 quarters · filed 2026-03-30 | $1.31M derived: sum of 3 quarters · filed 2026-03-30 | $2.05M 10-K · filed 2026-03-30 |
| 2024-09-30 | $386.73K 10-Q · filed 2025-11-14 | $902.35K derived: sum of 2 quarters · filed 2025-11-14 | $1.65M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $515.62K 10-Q · filed 2025-08-13 | $1.26M 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | $746.15K 10-Q · filed 2025-05-14 | |||
| 2023-12-31 | $1.98M 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |